Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical study evaluating SYS6043 for advanced/metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk [NA]
Clinical trial update NCT06051214 evaluating thrombin generation as a predictor of thromboembolic events in oncology patients at risk; curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection [Phase 2]
Phase 2 clinical trial evaluating donor CMV-specific cytotoxic T lymphocytes for persistent cytomegalovirus infection in patients with hemat…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours [Phase 1]
A Phase 1 immuno-PET study of the radiolabeled tracer 89Zr-S095012 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
This clinical trial update describes a Phase 1 study of XB371 in participants with locally advanced or metastatic solid tumors, currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors [Phase 1, Phase 2]
Nous-209 genetic vaccine trial for microsatellite instability-high solid tumors is in Phase 1/Phase 2 and not currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study evaluating PEP08 in MTAP-deleted advanced or metastatic solid tumors is currently recruiting. The sponsor is PharmaEngine.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
The study investigates cachexia frequency in ambulatory cancer patients and the psychological burden on patients and their primary caregiver…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors [Phase 1]
This document provides an update on a Phase 1 trial evaluating BNT317 for advanced solid tumors. It discusses safety and early signals of ef…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
This clinical trial update describes a planned network meta-analysis comparing different olanzapine dose regimens for preventing chemotherap…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating GW5282 in participants with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: HEAT Trial (HER2 Antibody Therapy With Lutetium-177) [EARLY_Phase 1]
This update announces that the HEAT trial, a Phase 1 study of a HER2-targeted antibody therapy with Lutetium-177, is currently recruiting fo…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Phase 1b/2 multisite dose-finding and expansion study of WTX-330 in adults with selected advanced or metastatic solid tumors or Non-Hodgkin …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Genomic Profiling in Cancer Patients
Clinical trial update from Memorial Sloan Kettering Cancer Center describes genomic profiling in cancer patients and indicates the study is …
-
CLINICAL_TRIALS other · 2026-02-10Clinical Trial Update: An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). [Phase 1, Phase 2]
An open-label dose-finding Phase 1/2 clinical trial of PTT-4256 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection [Phase 1]
Phase 1 clinical trial update for BAT8008 evaluating safety, tolerability, and pharmacokinetics. The study is currently recruiting in patien…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
This ClinicalTrials.gov update describes a Phase I/II randomized study evaluating NBTXR3 activated by abscopal or RadScopal radiation in com…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
A SWOG trial is recruiting to develop a method for predicting toxicity risk from immune checkpoint inhibitors in patients with malignant sol…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors [Phase 1]
Phase 1 trial evaluating mRNA-4106 alone and in combination with immune checkpoint blockade in participants with solid tumors; the study is …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Open-label, first-in-human dose-escalation and dose-expansion Phase I/II trial evaluating SPR1020 in patients with advanced solid tumors to …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours [Phase 1]
This Phase 1 study evaluates the safety, tolerability, and pharmacokinetics of MSP008-22 in patients with advanced solid tumors. The trial s…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Phase II Study of LM-24C5 [Phase 2]
Phase II study of LM-24C5 for advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors [Phase 1]
Phase 1 safety and efficacy study of HCB101, an Fc-fusion protein targeting the SIRPα-CD47 pathway, in advanced solid tumors and refractory …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Screening Study for Participants With Malignant Tumors [Phase 2]
This entry notes the completion of a Phase 2 screening study for participants with malignant solid tumors sponsored by Hoffmann-La Roche. Th…